Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.

Tang H, Shen N, Jin H, Liu D, Miao X, Zhu LQ.

Mol Neurobiol. 2013 Dec;48(3):404-11. doi: 10.1007/s12035-013-8414-x. Epub 2013 Feb 27.

PMID:
23440732
2.

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.

Szczepankiewicz A, Skibinska M, Hauser J, Slopien A, Leszczynska-Rodziewicz A, Kapelski P, Dmitrzak-Weglarz M, Czerski PM, Rybakowski JK.

Neuropsychobiology. 2006;53(1):51-6. Epub 2006 Jan 4.

PMID:
16397405
3.

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.

Lee KY, Ahn YM, Joo EJ, Jeong SH, Chang JS, Kim SC, Kim YS.

Neurosci Lett. 2006 Mar 6;395(2):175-8. Epub 2005 Nov 14.

PMID:
16289845
4.

Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.

Pandey GN, Rizavi HS, Tripathi M, Ren X.

Bipolar Disord. 2015 Mar;17(2):160-71. doi: 10.1111/bdi.12228. Epub 2014 Jul 8.

5.

Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.

Benedetti F, Poletti S, Radaelli D, Locatelli C, Pirovano A, Lorenzi C, Vai B, Bollettini I, Falini A, Smeraldi E, Colombo C.

Psychopharmacology (Berl). 2015 Apr;232(7):1325-36. doi: 10.1007/s00213-014-3770-4. Epub 2014 Oct 28.

PMID:
25345732
6.

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.

Lin YF, Huang MC, Liu HC.

J Affect Disord. 2013 May;147(1-3):401-6. doi: 10.1016/j.jad.2012.08.025. Epub 2012 Sep 27.

PMID:
23021822
7.

Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.

Blasi G, Napolitano F, Ursini G, Di Giorgio A, Caforio G, Taurisano P, Fazio L, Gelao B, Attrotto MT, Colagiorgio L, Todarello G, Piva F, Papazacharias A, Masellis R, Mancini M, Porcelli A, Romano R, Rampino A, Quarto T, Giulietti M, Lipska BK, Kleinman JE, Popolizio T, Weinberger DR, Usiello A, Bertolino A.

Am J Psychiatry. 2013 Aug;170(8):868-76. doi: 10.1176/appi.ajp.2012.12070908.

PMID:
23598903
8.

Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.

Scassellati C, Rotondo A, Bonvicini C, Rossi G, Cassano GB, Gennarelli M.

Psychiatr Genet. 2007 Aug;17(4):249-50. No abstract available.

PMID:
17621172
9.

A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.

Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, Smeraldi E.

Neurosci Lett. 2004 Jan 23;355(1-2):37-40.

PMID:
14729229
10.

Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.

Benedetti F, Poletti S, Radaelli D, Bernasconi A, Cavallaro R, Falini A, Lorenzi C, Pirovano A, Dallaspezia S, Locatelli C, Scotti G, Smeraldi E.

Genes Brain Behav. 2010 Jun 1;9(4):365-71. doi: 10.1111/j.1601-183X.2010.00566.x. Epub 2010 Jan 25.

11.

Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.

Lavoie J, Hébert M, Beaulieu JM.

Biol Psychiatry. 2014 Jul 15;76(2):93-100. doi: 10.1016/j.biopsych.2013.08.035. Epub 2013 Oct 17.

PMID:
24138923
12.

The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.

Lee YJ, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1303-8. doi: 10.1016/j.pnpbp.2011.04.006. Epub 2011 Apr 23.

PMID:
21549170
13.

Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.

Park SW, Lee JG, Kong BG, Lee SJ, Lee CH, Kim JI, Kim YH.

Psychiatry Clin Neurosci. 2009 Aug;63(4):433-9. doi: 10.1111/j.1440-1819.2009.01976.x. Epub 2009 Apr 27.

14.

[Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].

Ivanova SA, Losenkov IS, Bokhan NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6):93-100. Review. Russian.

PMID:
25075421
15.

Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.

Bersudsky Y, Shaldubina A, Kozlovsky N, Woodgett JR, Agam G, Belmaker RH.

Behav Pharmacol. 2008 May;19(3):217-24. doi: 10.1097/FBP.0b013e3282feb099.

PMID:
18469539
16.

[Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].

Numajiri M, Aoki J, Iwahashi K, Fukamauchi F, Enomoto M, Yoshihara E, Murayama O, Nishizawa D, Ikeda K, Ishigooka J.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Jun;32(3):161-3. Japanese.

PMID:
22834106
17.

Association between glycogen synthase kinase-3β gene polymorphisms and attention deficit hyperactivity disorder in Korean children: a preliminary study.

Shim SH, Hwangbo Y, Kwon YJ, Lee HY, Kim JH, Yoon HK, Hwang JA, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):57-61. doi: 10.1016/j.pnpbp.2012.05.008. Epub 2012 May 31.

PMID:
22658982
18.

Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.

Ronai Z, Kovacs-Nagy R, Szantai E, Elek Z, Sasvari-Szekely M, Faludi G, Benkovits J, Rethelyi JM, Szekely A.

Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):217-22. doi: 10.1002/ajmg.b.32223. Epub 2014 Feb 21.

19.
20.

Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.

Chen G, Tang J, Yu G, Chen Y, Wang L, Zhang Y.

Mol Biol Rep. 2014 Sep;41(9):5711-8. doi: 10.1007/s11033-014-3441-x. Epub 2014 Jun 15.

PMID:
24929537

Supplemental Content

Support Center